ANIP up +3.37% percent Today $ANIP High is at 56.74 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:58 AM

ANIP up +3.37% percent Today $ANIP High is at 56.74 and the Low 54.01 with current volume of 81,477.

Recent News posted below.

ANI Pharmaceuticals Inc ANIP other info.
http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/

ANIP ANI Pharmaceuticals Inc Recent Headline News

Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 12 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 56.01 (+2.06), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26), PBYI: 223.58 (+7.36)

Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 306.96 (+1.53), ANIP: 56.01 (+2.06), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26)

Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 56.01 (+2.06), ICPT: 159.47 (-3.11), AMAG: 34.69 (+0.69), AFFX: 9.45 (-0.26)

Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 56.01 (+2.06)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 56.01 (+2.06), SCMP: 11.94 (+0.64)

Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 56.01 (+2.06)

Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 306.96 (+1.53), ANIP: 56.01 (+2.06), CLDX: 17.90 (+3.74), AMAG: 34.69 (+0.69)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.57 (+0.11), ANIP: 56.01 (+2.06), ACGL: 56.85 (-0.45), ACCO: 8.96 (-0.03), FLWS: 8.84 (-0.15)

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 56.01 (+2.06)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.37 (-0.61), HBNK: 19.95 (+0.17), ASMI: 41.46 (+0.20), RRGB: 68.69 (+0.18), SAPE: 24.68 (unch), PLUG: 3.72 (unch), ANIP: 56.01 (+2.06), ODP: 6.57 (-0.22), MTEX: 21.98 (+1.67), JAXB: 11.75 (-0.15), ALQA: 5.10 (+0.05), YRCW: 23.46 (-0.27)

Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST

FRM: 6.13 (+0.05), NEO: 4.69 (+0.01), AU: 9.39 (-0.17), FNHC: 24.57 (-0.16), AMS: 2.53 (-0.19), NYMX: 0.57 (+0.02), AMDA: 1.37 (+0.15), CVD: 100.35 (+0.05), GBIM: 6.50 (+0.20), RCAP: 11.84 (-0.25), KBIO: 1.96 (-0.14), COOL: 0.81 (-0.09), SAPE: 24.68 (unch), XTLB: 2.58 (+0.13), GERN: 3.03 (+0.27), ANIP: 56.01 (+2.06), BBLU: 1.32 (+0.02), NXTD: 2.31 (unch), AP: 18.78 (-0.10), ALQA: 5.10 (+0.05)

ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST

ANIP: 56.01 (+2.06)

ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 56.01 (+2.06)

ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST

ANIP: 56.01 (+2.06)

ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 56.01 (+2.06)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.84 (+0.03), SYY: 38.86 (+0.28), L: 42.55 (-0.23), EEP: 37.93 (+0.59), SNH: 22.21 (+0.03), INN: 11.47 (-0.07), ITG: 19.61 (+0.10), NSP: 32.90 (-0.08), S: 5.01 (-0.04), ALE: 49.97 (+0.14), GVA: 35.92 (-0.35), MCY: 53.86 (-0.19), ARNA: 4.58 (+0.05), CHD: 73.72 (+0.19), ARE: 82.56 (+0.24), USAK: 18.56 (+0.11), BWP: 16.76 (-0.19), KRG: 26.18 (-0.02), CYOU: 22.74 (-1.13), MNKD: 6.22 (+0.06), HNT: 50.87 (+1.07), AMH: 17.24 (-0.03), ARCB: 42.42 (-0.19), ANIP: 56.01 (+2.06), AMG: 195.41 (-1.53), HAE: 36.98 (-0.15), SOHU: 49.42 (-1.54), CNA: 38.94 (-0.18)

ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.66 (+0.76), MACK: 8.70 (+0.22), ANIP: 56.01 (+2.06), ILMN: 182.54 (+2.04)

ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT

ANIP: 56.01 (+2.06)

5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 56.01 (+2.06), KTOS: 5.32 (-0.08), BLOX: 17.04 (+0.18), CSLT: 11.17 (-0.69), FPRX: 15.44 (+0.25)

ANI Pharmaceuticals Inc. (ANIP) Stock Research Links

ANIP Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Data Center Transformers on the Brink of a Boom

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Class Action Greenlighted Against Concordia for Title IX Violations

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Essity's SEK 850m Bet: Expanding Lilla Edet Facility

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

OI Investors Crack Down: Class Action Filing Looms

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Eve Air Mobility's Vector System Proves Its Worth

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

NueSynergy Secures Top Spot in HSA Provider Rankings

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

SciGround Launches: A Game-Changer in Research Verification

Unshackling Research Verification from the Model Folks, here's the big one—Licklider, Inc. from Tokyo lobbed a curveball with their new player in town: SciGround. This platform takes the reins on mathematically verifying AI-driven research, which is something you'll want to keep an eye on if you're at all interested in AI or research replication. Why SciGround Gets My...

JardogsHealth Taps Industry Titans for Growth Council

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Dahua's Pro Challenge 2026: Bridging Expertise Globally

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...